Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 027791/0309 | |
| Pages: | 4 |
| | Recorded: | 03/01/2012 | | |
Attorney Dkt #: | 2010_1538A |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
7
|
|
Patent #:
|
|
Issue Dt:
|
05/14/2002
|
Application #:
|
09486289
|
Filing Dt:
|
02/25/2000
|
Title:
|
METHOD OF PURIFYING DAUNOMYCIN
|
|
|
Patent #:
|
|
Issue Dt:
|
06/08/2004
|
Application #:
|
09555494
|
Filing Dt:
|
06/01/2000
|
Title:
|
CRYSTALLINE ANTHRACYCLINE ANTIBIOTIC AND PROCESS FOR PRODUCING THE SAME
|
|
|
Patent #:
|
|
Issue Dt:
|
05/10/2005
|
Application #:
|
09762230
|
Filing Dt:
|
02/05/2001
|
Title:
|
GENE PARTICIPATING IN THE PRODUCTION OF HOMO-GLUTAMIC ACID AND UTILIZATION THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
11/25/2003
|
Application #:
|
09807451
|
Filing Dt:
|
04/13/2001
|
Title:
|
CRYSTALLIZATION OF DOXORUBICIN HYDROCHLORIDE
|
|
|
Patent #:
|
|
Issue Dt:
|
04/04/2006
|
Application #:
|
10169257
|
Filing Dt:
|
06/28/2002
|
Publication #:
|
|
Pub Dt:
|
11/06/2003
| | | | |
Title:
|
PROCESS FOR THE BIOLOGICAL PRODUCTION OF L-PIPECOLIC ACID
|
|
|
Patent #:
|
|
Issue Dt:
|
06/26/2007
|
Application #:
|
10859149
|
Filing Dt:
|
06/03/2004
|
Publication #:
|
|
Pub Dt:
|
10/28/2004
| | | | |
Title:
|
AN ISOLATED NUCLEIC ACID ENCODING L-LYSINE: 2-OXOGLUTARIC ACID 6-AMINOTRANSFERASE
|
|
|
Patent #:
|
|
Issue Dt:
|
10/30/2012
|
Application #:
|
12994950
|
Filing Dt:
|
11/29/2010
|
Publication #:
|
|
Pub Dt:
|
05/12/2011
| | | | |
Title:
|
METHOD FOR PRODUCING CAMPTOTHECIN DERIVATIVES
|
|
Assignee
|
|
|
3-3-6 NIHONBASHIHONCHO, CHUO-KU |
TOKYO, JAPAN 103-0023 |
|
Correspondence name and address
|
|
WENDEROTH, LIND & PONACK, LLP
|
|
1030 15TH STREET, NW
|
|
SUITE 400 EAST
|
|
WASHINGTON, DC 20005
|
Search Results as of:
06/06/2024 03:45 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|